RAPT THERAPEUTICS INC. - COMMON STOCK
0.9152
01-May-25 15:45:00
15 minutes delayed
Stocks
-0.0116
-1.25%
Today's range
0.8510 - 0.9350
ISIN
N/A
Source
NASDAQ
-
RAPT Therapeutics Announces Pricing of Public Offering of Common Stock
15 Jun 2021 22:07:25 By Nasdaq GlobeNewswire
-
RAPT Therapeutics Announces Proposed Public Offering of Common Stock
14 Jun 2021 15:01:00 By Nasdaq GlobeNewswire
-
14 Jun 2021 07:00:01 By Nasdaq GlobeNewswire
-
RAPT Therapeutics to Report Top Line Data from Phase 1b Trial of RPT193 in Atopic Dermatitis
13 Jun 2021 15:00:00 By Nasdaq GlobeNewswire
-
RAPT Therapeutics to Present at the UBS Global Healthcare Virtual Conference
20 May 2021 15:00:00 By Nasdaq GlobeNewswire
-
RAPT Therapeutics Reports First Quarter 2021 Financial Results
11 May 2021 07:00:02 By Nasdaq GlobeNewswire
-
RAPT Therapeutics Completes Enrollment in Phase 1b Trial of RPT193 in Atopic Dermatitis
22 Mar 2021 07:00:01 By Nasdaq GlobeNewswire
-
RAPT Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results
11 Mar 2021 07:00:02 By Nasdaq GlobeNewswire
-
10 Mar 2021 15:30:00 By Nasdaq GlobeNewswire
-
RAPT Therapeutics to Participate in Two Investor Conferences in March
03 Mar 2021 07:00:01 By Nasdaq GlobeNewswire
-
RAPT Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
19 Feb 2021 07:00:00 By Nasdaq GlobeNewswire
-
RAPT Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
05 Jan 2021 07:00:01 By Nasdaq GlobeNewswire